Treatment of granuloma annulare with tranilast.

Abstract	Three cases of granuloma annulare which did not exhibit a self-limited course were treated with tranilast at the dose of 300 mg/daily. The treatment resulted in the resolution of skin lesions within three months of administration. Although spontaneous resolution is often observed in granuloma annulare, tranilast may provide an alternative therapy for the treatment of cases resistant to spontaneous healing.
Authors	H Yamada, A Ide, M Sugiura, S Kurihara, S Tajima
Journal	The Journal of dermatology (J Dermatol) Vol. 22 Issue 5 Pg. 354-6 (May 1995) ISSN: 0385-2407 [Print] England
PMID	7545709 (Publication Type: Case Reports, Journal Article)
Chemical References	Anti-Inflammatory Agents, Non-Steroidal Histamine H1 Antagonists ortho-Aminobenzoates tranilast
Topics	Adult Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use) Arm Biopsy, Needle Female Granuloma Annulare (diagnosis, drug therapy, physiopathology) Histamine H1 Antagonists (administration & dosage, therapeutic use) Humans Male Middle Aged Thorax ortho-Aminobenzoates (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!